Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, and RNA modifications and cancer.
Sequential omics analysis reveals molecular signatures of malignant transformation in recurrent meningiomas.
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma.
RNA Oncological Therapeutics: Intracellular Hairpin RNA Assembly Enables MicroRNA-Triggered Anticancer Functionality.
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival.
m6ATM: a deep learning framework for demystifying the m6A epitranscriptome with Nanopore long-read RNA-seq data.
Region-specific DNA hydroxymethylation along the malignant progression of IDH-mutant gliomas.
Multiancestry genomic and transcriptomic analysis of gastric cancer
Multiancestry genomic and transcriptomic analysis of gastric cancer.
Loss of viral genome with altered immune microenvironment during tumour progression of Epstein-Barr virus-associated gastric carcinoma.
Data from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression
Supplementary Figure from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression
Data from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression
Supplementary Figure from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression
Supplementary Data from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression
Supplementary Table from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression
Supplementary Data from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression
Supplementary Table from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia.
Genome-wide analysis of DNA methylation identifies the apoptosis-related gene UQCRH as a tumor suppressor in renal cancer.
Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism.
Molecular classification and diagnostics of upper urinary tract urothelial carcinoma
Molecular classification and diagnostics of upper urinary tract urothelial carcinoma.
Genetic and epigenetic basis of hepatoblastoma diversity.
TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma.
Base-resolution analysis of 5-hydroxymethylcytidine by selective oxidation and reverse transcription arrest.
Pan-cancer analysis of whole genomes.
Two distinct modes of DNMT1 recruitment ensure stable maintenance DNA methylation.
Sex differences in oncogenic mutational processes.